OJPM  Vol.2 No.4 , November 2012
The effects of obesity on venous thromboembolism: A review
ABSTRACT
Obesity has emerged as a global health issue that is associated with wide spectrum of disorders, including coronary artery disease, diabetes mellitus, hypertension, stroke, and venous thromboembolism (VTE). VTE is one of the most common vascular disorders in the United States and Europe and is associated with significant mortality. Although the association between obesity and VTE appears to be moderate, obesity can interact with other environmental or genetic factors and pose a significantly greater risk of VTE among individuals who are obese and who are exposed simultaneously to several other risk factors for VTE. Therefore, identification of potential interactions between obesity and certain VTE risk factors might offer some critical points for VTE interventions and thus minimize VTE morbidity and mortality among patients who are obese. However, current obesity measurements have limitations and can introduce contradictory results in the outcome of obesity. To overcome these limitations, this review proposes several future directions and suggests some avenues for prevention of VTE associated with obesity as well.

Cite this paper
Yang, G. , Staercke, C. and Hooper, W. (2012) The effects of obesity on venous thromboembolism: A review. Open Journal of Preventive Medicine, 2, 499-509. doi: 10.4236/ojpm.2012.24069.
References
[1]   Giuntini, C., Di Ricco, G., Marini, C., Melillo, E. and Palla, A. (1995) Pulmonary embolism: Epidemiology. Chest, 107, 3S-9S. doi:10.1378/chest.107.1_Supplement.3S

[2]   Goldhaber, S.Z. (2012) Venous thromboembolism: Epidemiology and magnitude of the problem. Best Practice & Research Clinical Haematology, 25, 235-242. doi:10.1016/j.beha.2012.06.007

[3]   Silverstein, M.D., Heit, J.A., Mohr, D.N., Petterson, T.M., O'Fallon, W.M. and Melton, L.J., III. (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Archives of Internal Medicine, 158, 585-593. doi:10.1001/archinte.158.6.585

[4]   Spencer, F.A., Emery, C., Lessard, D., Anderson, F., Emani, S., Aragam, J., et al. (2006) The Worcester venous thromboembolism study: A population-based study of the clinical epidemiology of venous thromboembolism. Journal of General Internal Medicine, 21, 722-727. doi:10.1111/j.1525-1497.2006.00458.x

[5]   White, R.H., Zhou, H., Murin, S. and Harvey, D. (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Journal of Thrombosis and Haemostasis, 93, 298-305.

[6]   Kahn, S.R. (2006) Frequency and determinants of the postthrombotic syndrome after venous thromboembolism. Current Opinion in Pulmonary Medicine, 12, 299-303. doi:10.1097/01.mcp.0000239543.40078.17

[7]   Ruppert, A., Steinle, T. and Lees, M. (2011) Economic burden of venous thromboembolism: A systematic review. Journal of Medical Economics, 14, 65-74. doi:10.3111/13696998.2010.546465

[8]   Popkin, B.M., Adair, L.S. and Ng, S.W. (2012) Global nutrition transition and the pandemic of obesity in developing countries. Nutrition Reviews, 70, 3-21. doi:10.1111/j.1753-4887.2011.00456.x

[9]   Schelbert, K.B. (2009) Comorbidities of obesity. Primary Care, 36, 271-285. doi:10.1016/j.pop.2009.01.009

[10]   Nejat, E.J., Polotsky, A.J. and Pal, L. (2010) Predictors of chronic disease at midlife and beyond—the health risks of obesity. Maturitas, 65, 106-111. doi:10.1016/j.maturitas.2009.09.006

[11]   Kahn, S.R. (2011) The post thrombotic syndrome. Thrombosis Research, 127, S89-S92. doi:10.1016/S0049-3848(11)70024-X

[12]   Kim, N.H. and Lang, I.M. (2012) Risk factors for chronic thromboembolic pulmonary hypertension. European Respiratory Review, 21, 27-31. doi:10.1183/09059180.00009111

[13]   Hardziyenka, M., Campian, M.E., Reesink, H.J., Surie, S., Bouma, B.J., Groenink, M., et al. (2011) Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass evidence for atrophic remodeling. Journal of the American College of Cardiology, 57, 921-928. doi:10.1016/j.jacc.2010.08.648

[14]   Schulman, S., Lindmarker, P., Holmstrom, M., Larfars, G., Carlsson, A., Nicol, P., et al. (2006) Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. Journal of Thrombosis and Haemostasis, 4, 734-742. doi:10.1111/j.1538-7836.2006.01795.x

[15]   Schneider, D., Lilienfeld, D.E. and Im, W. (2006) The epidemiology of pulmonary embolism: Racial contrasts in incidence and in-hospital case fatality. National Medical Association, 98, 1967-1972.

[16]   Stein, P.D., Kayali, F., Olson, R.E. and Milford, C.E. (2004) Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: Analysis of data from the national hospital discharge survey and the United States bureau of the census. American Journal of Medicine, 116, 435-442. doi:10.1016/j.amjmed.2003.11.020

[17]   Stein, P.D., Hull, R.D., Kayali, F., Ghali, W.A., Alshab, A.K. and Olson, R.E. (2004) Venous thromboembolism according to age: The impact of an aging population. Archives of Internal Medicine, Archives of Internal Medicine, 164, 2260-2265. doi:10.1001/archinte.164.20.2260

[18]   Amin, A.N., Varker, H., Princic, N., Lin, J., Thompson, S. and Johnston, S. (2012) Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. Journal of Hospital Medicine, 7, 231-238.

[19]   Stein, P.D. and Matta, F. (2010) Epidemiology and incidence: The scope of the problem and risk factors for development of venous thromboembolism. Clinics in Chest Medicine, 31, 611-628. doi:10.1016/j.ccm.2010.07.001

[20]   Barlow, S.E. (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics, 120, S164-S192. doi:10.1542/peds.2007-2329C

[21]   Wang, Y.C., Gortmaker, S.L. and Taveras, E.M. (2011) Trends and racial/ethnic disparities in severe obesity among US children and adolescents, 1976-2006. International Journal of Pediatric Obesity, 21, 176-182.

[22]   Czernichow, S., Kengne, A.P., Stamatakis, E., Hamer, M. and Batty, G.D. (2011) Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: Evidence from an individual-participant meta-analysis of 82,864 participants from nine cohort studies. Obesity Reviews, 12, 680-687.

[23]   Borch, K.H., Braekkan, S.K., Mathiesen, E.B., Njolstad, I., Wilsgaard, T., Stormer, J., et al. (2010) Anthropometric measures of obesity and risk of venous thromboembolism: The Tromso study. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 121-127. doi:10.1161/ATVBAHA.109.188920

[24]   Maffeis, C., Banzato, C. and Talamini, G. (2008) Waist- to-height ratio, a useful index to identify high metabolic risk in overweight children. Journal of Pediatrics, 152, 207-213. doi:10.1016/j.jpeds.2007.09.021

[25]   WHO (2008) Waist circumference and waist-hip ratio: Report of a WHO expert consultation. WHO, Geneva. http://whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf

[26]   Thomas, E.L., Saeed, N., Hajnal, J.V., Brynes, A., Goldstone, A.P., Frost, G., et al. (1998) Magnetic resonance imaging of total body fat. Journal of Applied Physiology, 85, 1778-1785.

[27]   Wang, Z., Heymsfield, S.B., Chen, Z., Zhu, S. and Pierson, R.N. (2010) Estimation of percentage body fat by dual-energy x-ray absorptiometry: Evaluation by in vivo human elemental composition. Physics in Medicine and Biology, 55, 2619-2635. doi:10.1088/0031-9155/55/9/013

[28]   Jackson, A.S., Stanforth, P.R., Gagnon, J., Rankinen, T., Leon, A.S., Rao, D.C., et al. (2002) The effect of sex, age and race on estimating percentage body fat from body mass index: The heritage family study. International Journal of Obesity and Related Metabolic Disorders, 26, 789-796.

[29]   Muth, N.D. (2009) What are the guidelines for percentage of body fat loss? American Council on Exercise (ACE). Ask the Expert Blog.

[30]   Deurenberg, P., Yap, M., van Staveren, W.A. (1998) Body mass index and percent body fat: A meta analysis among different ethnic groups. International Journal of Obesity and Related Metabolic Disorders, 22, 1164-1171. doi:10.1038/sj.ijo.0800741

[31]   Ageno, W., Becattini, C., Brighton, T., Selby, R. and Kamphuisen, P.W. (2008) Cardiovascular risk factors and venous thromboembolism: A meta-analysis. Circulation, 117, 93-102. doi:10.1161/CIRCULATIONAHA.107.709204

[32]   Borch, K.H., Braekkan, S.K., Mathiesen, E.B., Njolstad, I., Wilsgaard, T., Stormer, J., et al. (2009) Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: The Tromso study. Journal of Thrombosis and Haemostasis, 7, 739-745. doi:10.1111/j.1538-7836.2008.03234.x

[33]   Steffen, L.M., Cushman, M., Peacock, J.M., Heckbert, S.R., Jacobs, D.R., Jr., Rosamond, W.D., et al. (2009) Metabolic syndrome and risk of venous thromboembolism: Longitudinal investigation of thromboembolism etiology. Journal of Thrombosis and Haemostasis, 7, 746-751. doi:10.1111/j.1538-7836.2009.03295.x

[34]   Kabrhel, C., Varraso, R., Goldhaber, S.Z., Rimm, E.B. and Camargo, C.A. (2009) Prospective study of BMI and the risk of pulmonary embolism in women. Obesity, 17, 2040-2046. doi:10.1038/oby.2009.92

[35]   Eichinger, S., Hron, G., Bi-alonczyk, C., Hirschl, M., Minar, E., Wagner, O., et al. (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Archives of Internal Medicine, 168, 1678-1683. doi:10.1001/archinte.168.15.1678

[36]   Severinsen, M.T., Kristensen, S.R., Johnsen, S.P., Dethlefsen, C., Tjonneland, A. and Overvad, K. (2009) Anthropometry, body fat, and venous thromboembolism: A Danish follow-up study. Circulation, 120, 1850-1857. doi:10.1161/CIRCULATIONAHA.109.863241

[37]   Finkelstein, E.A., Khavjou, O.A., Thompson, H., Trogdon, J.G., Pan, L., Sherry, B., et al. (2012) Obesity and severe obesity forecasts through 2030. American Journal of Preventive Medicine, 42, 563-570. doi:10.1016/j.amepre.2011.10.026

[38]   Garcia-Fuster, M.J., Forner, M.J., Fernandez, C., Gil, J., Vaya, A. and Maldonado, L. (2005) Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol Haemost Thromb, 34, 6-12. doi:10.1159/000088541

[39]   Linnemann, B., Zgouras, D., Schindewolf, M., Schwonberg, J., Jarosch-Preusche, M. and Lindhoff-Last, E. (2008) Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: Results from the German MAISTHRO registry. Blood Coagulation & Fibrinolysis, 19, 159-165. doi:10.1097/MBC.0b013e3282f54558

[40]   Barba, R., Zapatero, A., Losa, J.E., Valdes, V., Todoli, J.A., Di Micco, P., et al. (2008) Body mass index and mortality in patients with acute venous thromboembolism: Findings from the RIETE registry. Journal of Thrombosis and Haemostasis, 6, 595-600. doi:10.1111/j.1538-7836.2008.02907.x

[41]   Stein, P.D., Matta, F. and Goldman, J. (2011) Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox. Thrombosis Research, 128, 518- 523. doi:10.1016/j.thromres.2011.10.019

[42]   Kalantar-Zadeh, K., Horwich, T.B., Oreopoulos, A., Kovesdy, C.P., Younessi, H., Anker, S.D., et al. (2007) Risk factor paradox in wasting diseases. Current Opinion in Clinical Nutrition & Metabolic Care, 10, 433-442. doi:10.1097/MCO.0b013e3281a30594

[43]   Janssen, I. and Bacon, E. (2008) Effect of current and midlife obesity status on mortality risk in the elderly. Obesity, 16, 2504-2509. doi:10.1038/oby.2008.400

[44]   Newman, A.B., Yanez, D., Harris, T., Duxbury, A., Enright, P.L. and Fried, L.P. (2001) Weight change in old age and its association with mortality. Journal of the American Geriatrics Society, 49, 1309-1318. doi:10.1046/j.1532-5415.2001.49258.x

[45]   Sorkin, J.D., Muller, D.C. and Andres, R. (1999) Longitudinal change in height of men and women: Implications for interpretation of the body mass index: The Baltimore longitudinal study of Aging. American Journal of Epidemiology, 150, 969-977. doi:10.1093/oxfordjournals.aje.a010106

[46]   Oreopoulos, A., Kalantar-Zadeh, K., Sharma, A.M. and Fonarow, G.C. (2009) The obesity paradox in the elderly: Potential mechanisms and clinical implications. Clinics in Geriatric Medicine, 25, 643-659. doi:10.1016/j.cger.2009.07.005

[47]   Zamboni, M., Mazzali, G., Zoico, E., Harris, T.B., Meigs, J.B., Di Francesco, V., et al. (2005) Health consequences of obesity in the elderly: A review of four unresolved questions. International Journal of Obesity, 29, 1011-1029. doi:10.1038/sj.ijo.0803005

[48]   Chang, S.H., Beason, T.S., Hunleth, J.M. and Colditz, G.A. (2012) A systematic review of body fat distribution and mortality in older people. Maturitas, 72, 175-191. doi:10.1016/j.maturitas.2012.04.004

[49]   Vaya, A., Martinez-Triguero, M.L., Espana, F., Todoli, J.A., Bonet, E. and Corella, D. (2011) The metabolic syndrome and its individual components: Its association with venous thromboembolism in a Mediterranean population. Metabolic Syndrome and Related Disorders, 9, 197-201. doi:10.1089/met.2010.0117

[50]   Eikelboom, J.W. and Weitz, J.I. (2011) Importance of family history as a risk factor for venous thromboembolism. Circulation, 124, 996-997. doi:10.1161/CIRCULATIONAHA.111.048868

[51]   Osinbowale, O., Ali, L. and Chi, Y.W. (2010) Venous thromboembolism: A clinical review. Postgraduate Medicine, 122, 54-65. doi:10.3810/pgm.2010.03.2122

[52]   Mili, F.D., Hooper, W.C., Lally, C. and Austin, H. (2011) The impact of comorbid conditions on family history of venous thromboembolism in whites and blacks. Thrombosis Research, 127, 309-316. doi:10.1016/j.thromres.2010.12.012

[53]   Margaglione, M. and Grandone, E. (2011) Population genetics of venous throm-boembolism. A narrative review. Thrombosis and Haemostasis, 105, 221-231. doi:10.1160/TH10-08-0510

[54]   Emmerich, J., Rosendaal, F.R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., et al. (2001) Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism—pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study group for pooled-analysis in venous thromboembolism. Thrombosis and Haemostasis, 86, 809-816.

[55]   Delluc, A., Le Moigne, E., Tromeur, C., Noel-Savina, E., Couturaud, F., Mottier, D., et al. (2011) Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study. British Journal of Haematology, 154, 486-491. doi:10.1111/j.1365-2141.2011.08592.x

[56]   Severinsen, M.T., Overvad, K., Johnsen, S.P., Dethlefsen, C., Madsen, P.H., Tjonneland, A., et al. (2010) Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. British Journal of Haematology, 149, 273-279. doi:10.1111/j.1365-2141.2010.08086.x

[57]   Canonico, M., Plu-Bureau, G., Lowe, G.D. and Scarabin, P.Y. (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: Systematic review and meta-analysis. British Medical Journal, 336, 1227-1231. doi:10.1136/bmj.39555.441944.BE

[58]   Cushman, M., Kuller, L.H., Prentice, R., Rodabough, R.J., Psaty, B.M., Stafford, R.S., et al. (2004) Estrogen plus progestin and risk of venous thrombosis. Journal of the American Medical Association, 292, 1573-1580. doi:10.1001/jama.292.13.1573

[59]   Petitti, D.B. (2003) Clinical practice. Combination estrogen-progestin oral contraceptives. New England Journal of Medicine, 349, 1443-1450. doi:10.1056/NEJMcp030751

[60]   Ettinger, B., Wang, S.M., Leslie, R.S., Patel, B.V., Boulware, M.J., Mann, M.E., et al. (2011) Evolution of post-menopausal hormone therapy between 2002 and 2009. Menopause, 19, 610-615.

[61]   Davey, D.A. (2012) Update: Estrogen and estrogen plus progestin therapy in the care of women at and after the menopause. Women’s Health, 8, 169-189. doi:10.2217/whe.12.1

[62]   Schmidt, P. (2012) The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause, 19, 257-271.

[63]   Canonico, M., Oger, E., Conard, J., Meyer, G., Levesque, H., Trillot, N., et al. (2006) Obesity and risk of venous thromboembolism among postmenopausal women: Differential impact of hormone therapy by route of estrogen administration. The ESTHER study. Journal of Thrombosis and Haemostasis, 4, 1259-1265. doi:10.1111/j.1538-7836.2006.01933.x

[64]   Goodman, M.P. (2012) Are all estrogens created equal? A review of oral vs. transdermal therapy. Women’s Health, 21, 161-169. doi:10.1089/jwh.2011.2839

[65]   Ay, L., Kopp, H.P., Brix, J.M., Ay, C., Quehenberger, P., Schernthaner, G.H., et al. (2010) Thrombin generation in morbid obesity: Significant reduction after weight loss. Journal of Thrombosis and Haemostasis, 8, 759-765. doi:10.1111/j.1538-7836.2010.03766.x

[66]   Rosing, J., Mid-deldorp, S., Curvers, J., Christella, M., Thomassen, L.G., Nicolaes, G.A., et al. (1999) Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study. Lancet, 354, 2036-2040. doi:10.1016/S0140-6736(99)06092-4

[67]   Hoibraaten, E., Mowinckel, M.C., de Ronde, H., Bertina, R.M. and Sandset, P.M. (2001) Hormone replacement therapy and acquired resistance to activated protein C: Results of a randomized, double-blind, placebo-controlled trial. British Journal of Haematology, 115, 415-420. doi:10.1046/j.1365-2141.2001.03111.x

[68]   Middeldorp, S., Meijers, J.C., van den Ende, A.E., van Enk, A., Bouma, B.N., Tans, G., et al. (2000) Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: A cross-over study. Thrombosis and Haemostasis, 84, 4-8.

[69]   Scarabin, P.Y., Alhenc-Gelas, M., Plu-Bureau, G., Taisne, P., Agher, R. and Aiach, M. (1997) Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 3071-3078. doi:10.1161/01.ATV.17.11.3071

[70]   Post, M.S., Christella, M., Thomassen, L.G., van der Mooren, M.J., van Baal, W.M., Rosing, J., et al. (2003) Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: A randomized, placebo-controlled study in post-menopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1116-1121. doi:10.1161/01.ATV.0000074146.36646.C8

[71]   Conard, J., Samama, M., Basdevant, A., Guy-Grand, B. and de Lignieres, B. (1983) Differential AT III-response to oral and parenteral administration of 17 betaestradiol. Thrombosis and Haemostasis, 49, 252.

[72]   Karim, R., Mack, W.J., Hodis, H.N., Roy, S. and Stanczyk, F.Z. (2009) Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postme-nopausal women. Journal of Clinical Endocrinology & Metabolism, 94, 4136-4143. doi:10.1210/jc.2009-0643

[73]   O'Rourke, R.W., White, A.E., Metcalf, M.D., Olivas, A.S., Mitra, P., Larison, W.G., et al. (2011) Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia, 54, 1480-1490. doi:10.1007/s00125-011-2103-y

[74]   Tordjman, J., Guerre-Millo, M. and Clement, K. (2008) Adipose tissue inflammation and liver pathology in human obesity. Diabetes & Metabolism, 34, 658-663. doi:10.1016/S1262-3636(08)74601-9

[75]   Subauste, A.R. and Burant, C.F. (2007) Role of FoxO1 in FFA-induced oxidative stress in adipocytes. American Journal of Physiology Endocrinology and Metabolism, 293, E159-E164. doi:10.1152/ajpendo.00629.2006

[76]   Gorlach, A. (2005) Redox regulation of the coagulation cascade. Antioxidants & Redox Signaling, 7, 1398-1404. doi:10.1089/ars.2005.7.1398

[77]   Kalupahana, N.S. and Moustaid-Moussa, N. (2012) The renin-angiotensin system: A link between obesity, inflammation and insulin resistance. Obesity Reviews, 13, 136-149. doi:10.1111/j.1467-789X.2011.00942.x

[78]   Miyagawa, R., Asakura, T., Nakamura, T., Okada, H., Iwaki, S., Sobel, B.E., et al. (2010) Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3’-untranslated region of the PAI-1 gene and its pharmacologic implications. Coronary Artery Disease, 21, 144-150. doi:10.1097/MCA.0b013e328335790e

[79]   Meerarani, P., Badimon, J.J., Zias, E., Fuster, V. and Moreno, P.R. (2006) Metabolic syndrome and diabetic atherothrombosis: Implications in vascular complications. Current Molecular Medicine, 6, 501-514. doi:10.2174/156652406778018680

[80]   van Schouwenburg, I.M., B, K.M., NJ, M.V., SJ, L.B., H, C.K.N., Meijer, K., et al. (2012) Insulin resistance and risk of venous thromboembolism: Results of a population-based cohort study. Journal of Thrombosis and Haemostasis, 10, 1012-1018. doi:10.1111/j.1538-7836.2012.04707.x

[81]   Sturm, R. (2007) Increases in morbid obesity in the USA: 2000-2005. Public Health, 121, 492-496. doi:10.1016/j.puhe.2007.01.006

[82]   Lindahl, B., Nilsson, T.K., Jansson, J.H., Asplund, K. and Hallmans, G. (1999) Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. Journal of Internal Medicine, 246, 105-112. doi:10.1046/j.1365-2796.1999.00537.x

[83]   Van Guilder, G.P., Hoetzer, G.L., Smith, D.T., Irmiger, H.M., Greiner, J.J., Stauffer, B.L., et al. (2005) Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. American Journal of Physiology Endocrinology and Metabolism, 289, E807-E813. doi:10.1152/ajpendo.00072.2005

[84]   Lutsey, P.L., Virnig, B.A., Durham, S.B., Steffen, L.M., Hirsch, A.T., Jacobs, D.R., Jr., et al. (2010) Correlates and consequences of venous thromboembolism: The Iowa Women’s Health Study. American Journal of Public Health, 100, 1506-1513. doi:10.2105/AJPH.2008.157776

[85]   Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Polak, J.F. and Folsom, A.R. (2002) Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine, 162, 1182-1189. doi:10.1001/archinte.162.10.1182

[86]   Borch, K.H., Hansen-Krone, I., Braekkan, S.K., Mathiesen, E.B., Njolstad, I., Wilsgaard, T., et al. (2010) Physical activity and risk of venous thromboembolism. The Tromso study. Haematologica, 95, 2088-2094. doi:10.3324/haematol.2009.020305

[87]   Glynn, R.J. and Rosner, B. (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. American Journal of Epidemiology, 162, 975-982. doi:10.1093/aje/kwi309

[88]   Varraso, R., Kabrhel, C., Goldhaber, S.Z., Rimm, E.B. and Camargo, C.A., Jr. (2012) Prospective study of diet and venous thromboembolism in US women and men. American Journal of Epidemiology, 175, 114-126. doi:10.1093/aje/kwr377

[89]   Glynn, R.J., Ridker, P.M., Goldhaber, S.Z., Zee, R.Y. and Buring, J.E. (2007) Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: Report from the women’s health study. Circulation, 116, 1497-1503. doi:10.1161/CIRCULATIONAHA.107.716407

[90]   Steffen, L.M., Folsom, A.R., Cushman, M., Jacobs, D.R., Jr. and Rosamond, W.D. (2007) Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: The longitudinal investigation of thromboembolism etiology. Circulation, 115, 188-195. doi:10.1161/CIRCULATIONAHA.106.641688

[91]   Lutsey, P.L., Steffen, L.M., Virnig, B.A. and Folsom, A.R. (2009) Diet and incident venous thromboembolism: The Iowa women’s health study. American Heart Journal, 157, 1081-1087. doi:10.1016/j.ahj.2009.04.003

[92]   Booyse, F.M., Pan, W., Grenett, H.E., Parks, D.A., Darley-Usmar, V.M., Bradley, K.M., et al. (2007) Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Annals of Epidemiology, 17, S24-S31. doi:10.1016/j.annepidem.2007.01.006

[93]   Canali, R., Ambra, R., Stelitano, C., Mattivi, F., Scaccini, C. and Virgili, F. (2007) A novel model to study the biological effects of red wine at the molecular level. British Journal of Nutrition, 97, 1053-1058. doi:10.1017/S0007114507657870

[94]   Ridker, P.M., Vaughan, D.E., Stampfer, M.J., Glynn, R.J. and Hennekens, C.H. (1994) Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. Journal of the American Medical Association, 272, 929-933. doi:10.1001/jama.1994.03520120039028

[95]   Lindqvist, P.G., Epstein, E. and Olsson, H. (2009) The relationship between lifestyle factors and venous thromboembolism among women: A report from the MISS study. British Journal of Haematology, 144, 234-240. doi:10.1111/j.1365-2141.2008.07460.x

[96]   Wattanakit, K., Lutsey, P.L., Bell, E.J., Gornik, H., Cushman, M., Heckbert, S.R., et al. (2012) Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thrombosis and Haemostasis, 108, 291-302.

[97]   Hansen-Krone, I.J., Braekkan, S.K., Enga, K.F., Wilsgaard, T. and Hansen, J.B. (2011) Alcohol consumption, types of alcoholic beverages and risk of venous thromboembolism —The Tromso study. Thrombosis and Haemostasis, 106, 272-278. doi:10.1160/TH11-01-0043

[98]   Sharif-Kashani, B., Shahabi, P., Raeissi, S., Behzadnia, N., Shoaraka, A., Shahrivari, M., et al. (2012) Assessment of PRophylaxis for venous thromboembolIsm in hospitalized patients: The MASIH study. Clinical and Applied Thrombosis/Hemostasis, 18, 462-468.

[99]   Freeman, A.L., Pendleton, R.C. and Rondina, M.T. (2010) Prevention of venous thromboembolism in obesity. Expert Review of Cardiovascular Therapy, 8, 1711-1721. doi:10.1586/erc.10.160

[100]   Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D.D. and Schuunemann, H.J. (2012) Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest, 141, 7S-47S.

[101]   Lewis, T.V., Johnson, P.N., Nebbia, A.M. and Dunlap, M. (2011) Increased enoxaparin dosing is required for obese children. Pediatrics, 127, e787-e790. doi:10.1542/peds.2010-0746

[102]   Roth-Yelinek, B. (2012) Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we undertreating our patients? European Journal of Internal Medicine, 23, 236-239. doi:10.1016/j.ejim.2011.11.005

[103]   Brunelli, A. (2012) Deep vein thrombosis/pulmonary embolism: Prophylaxis, diagnosis, and management. Thoracic Surgery Clinics, 22, 25-28. doi:10.1016/j.thorsurg.2011.08.014

[104]   Masoomi, H., Buchberg, B., Reavis, K.M., Mills, S.D., Stamos, M. and Nguyen, N.T. (2011) Factors predictive of venous thromboembolism in bariatric surgery. American Journal of Surgery, 77, 1403-1406.

[105]   Borch, K.H., Nyegaard, C., Hansen, J.B., Mathiesen, E.B., Njolstad, I., Wilsgaard, T., et al. (2011) Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromso Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 1439-1444. doi:10.1161/ATVBAHA.110.218925

[106]   Pomp, E.R., le Cessie, S., Rosendaal, F.R. and Doggen, C.J. (2007) Risk of venous thrombosis: Obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 139, 289-296. doi:10.1111/j.1365-2141.2007.06780.x

[107]   Braekkan, S.K., Borch, K.H., Mathiesen, E.B., Njolstad, I., Wilsgaard, T. and Hansen, J.B. (2010) Body height and risk of venous thromboembolism: The Tromso study. American Journal of Epidemiology, 171, 1109-1115. doi:10.1093/aje/kwq066

[108]   Correia, M.L. and Haynes, W.G. (2006) A role for plasminogen activator inhibitor-1 in obesity: From pie to PAI? Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2183-2185. doi:10.1161/01.ATV.0000244018.24120.70

[109]   Polednak, A.P. (2012) US mortality from liver cirrhosis and alcoholic liver disease in 1999-2004: Regional and state variation in relation to per capita alcohol consumption. Substance Use & Misuse, 47, 202-213. doi:10.3109/10826084.2011.635462

[110]   Ali, M., Ananthakrishnan, A.N., McGinley, E.L. and Saeian, K. (2011) Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: A nationwide analysis. Digestive Diseases and Sciences, 56, 2152-2159. doi:10.1007/s10620-011-1582-5

[111]   Ogden, C.L., Carroll, M.D., Kit, B.K. and Flegal, K.M. (2012) Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief, 56, 1-8.

 
 
Top